Tashkent, Republic of Uzbekistan, and Pegasus Pharmaceuticals Group Inc., BC, Canada, June 8, 2010 --- Pegasus Pharmaceuticals Group Inc. today announced that Pharmacopoeia Committee, Public Health Ministry of the Republic of Uzbekistan has issued a new drug approval for HemoMex™ Dammarane Sapogenins (Ginseng Sapogenins) Injection 2000 mg/100 ml on May 7, 2010.

A Selective Metabolites Compound Drug (SMCD)-based innovative HemoMex™ Dammarane Sapogenins Injection was approved as a prescription drug which can be used in combination with chemotherapeutic agents and/or radiotherapy for solid tumors, and used for the treatment of neutropenia complicated to chemotherapy and/or radiotherapy.